title: Regional characteristics of histamine uptake into neonatal rat astrocytes.
abstract: Histaminergic signalling constitutes an attractive target for treatment of neuropsychiatric disorders. One obstacle to developing new pharmacological options has been failure to identify putative specific histamine transporter responsible for histamine clearance. Although high-affinity histamine uptake was detected in neonatal cortical astrocytes, its existence in other brain regions remains largely unexplored. We investigated whether cerebellar and striatal astrocytes participate in histamine clearance and evaluated the role of organic cation transporters (OCT) in astroglial histamine transport. Kinetic and pharmacological characteristics of histamine transport were determined in cultured astrocytes derived from neonatal rat cerebellum, striatum and cerebral cortex. As well as astrocytes of cortical origin, cultured striatal and cerebellar astrocytes displayed temperature-sensitive, high-affinity histamine uptake. Exposure to ouabain or Na(+)-free medium, supplemented with choline chloride markedly depressed histamine transport in cortical astrocytes. Conversely, histamine uptake in striatal and cortical astrocytes was ouabain-resistant and was only partially diminished during incubation in the absence of Na(+). Also, histamine uptake remained unaltered upon exposure to OCT inhibitor corticosterone, although OCTs were expressed in cultured astrocytes. Finally, histamine transport in cerebellar and striatal astrocytes was not sensitive to antidepressants. Despite common characteristics, cerebellar astrocytes had lower affinity, but markedly higher transport capacity for histamine compared to striatal astrocytes. Collectively, we provide evidence to suggest that cerebellar, striatal as well as cortical astrocytes possess saturable histamine uptake systems, which are not operated by OCTs. In addition, our data indicate that Na(+)-independent histamine carrier predominates in cerebellar and striatal astrocytes, whereas Na(+)-dependent transporter underlies histamine uptake in cortical astrocytes. Our findings implicate a role for histamine transporters in regulation of extracellular histamine concentration in cerebellum and striatum. Inhibition of histamine uptake might represent a viable option to modulate histaminergic neurotransmission.
authors.affiliation: Department of Pharmacology and Experimental Toxicology, Faculty of Medicine, University of Ljubljana, Korytkova 2, 1001, Ljubljana, Slovenia.
authors.forename: Katja
authors.initials: K
authors.lastname: Perdan-Pirkmajer
authors.forename: Sergej
authors.initials: S
authors.lastname: Pirkmajer
authors.forename: Andreja
authors.initials: A
authors.lastname: Raztresen
authors.forename: Mojca
authors.initials: M
authors.lastname: Krzan
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001253:Astrocytes / Q000187:drug effects / Q000378:metabolism*; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects; D006632:Histamine / Q000378:metabolism*; D007700:Kinetics; D027701:Organic Cation Transport Proteins / Q000235:genetics / Q000378:metabolism; D010042:Ouabain / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
chemical_list: D027701:Organic Cation Transport Proteins; D012333:RNA, Messenger; D010042:Ouabain; D006632:Histamine
references.citation: Neuroscience. 2007 Jan 19;144(2):616-22
references.pmid: 17110048
references.citation: J Neurochem. 2012 Sep;122(5):872-82
references.pmid: 22776024
references.citation: Mol Pharmacol. 2001 Feb;59(2):358-66
references.pmid: 11160873
references.citation: Pharmacol Ther. 2009 Jan;121(1):89-99
references.pmid: 19022290
references.citation: J Mol Model. 2010 Jun;16(6):1151-8
references.pmid: 20013137
references.citation: Inflamm Res. 2009 Feb;58(2):94-102
references.pmid: 19184360
references.citation: Br J Pharmacol. 2006 Jan;147 Suppl 1:S82-8
references.pmid: 16402124
references.citation: J Neurochem. 2005 Sep;94(5):1427-37
references.pmid: 16000150
references.citation: Brain Res. 1984 Jan 16;291(1):103-9
references.pmid: 6697175
references.citation: J Neurosci. 1998 May 15;18(10):3554-62
references.pmid: 9570787
references.citation: Glia. 1992;6(1):9-18
references.pmid: 1355075
references.citation: Neuropharmacology. 1995 Nov;34(11):1543-7
references.pmid: 8606801
references.citation: Physiol Rev. 2008 Jul;88(3):1183-241
references.pmid: 18626069
references.citation: J Neurochem. 2008 Aug;106(3):1471-82
references.pmid: 18513366
references.citation: Glia. 1992;6(1):1-8
references.pmid: 1355074
references.citation: Eur J Neurosci. 2009 Jun;29(12):2363-74
references.pmid: 19490084
references.citation: Neuropharmacology. 2006 Jun;50(8):941-52
references.pmid: 16581093
references.citation: Proc Natl Acad Sci U S A. 2009 May 12;106(19):8043-8
references.pmid: 19416912
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):49-53
references.pmid: 9459572
references.citation: Methods. 2010 Apr;50(4):313-22
references.pmid: 20138998
references.citation: Br J Pharmacol. 2002 Jul;136(6):829-36
references.pmid: 12110607
references.citation: Neurochem Res. 1994 Oct;19(10):1249-56
references.pmid: 7534384
references.citation: J Biol Chem. 1998 Dec 4;273(49):32776-86
references.pmid: 9830022
references.citation: J Neurochem. 1984 Dec;43(6):1544-9
references.pmid: 6491668
references.citation: Inflamm Res. 2006 Apr;55 Suppl 1:S36-7
references.pmid: 16547817
references.citation: Agents Actions. 1990 Apr;30(1-2):237-9
references.pmid: 1973584
references.citation: Neuroscience. 2007 May 25;146(3):1193-211
references.pmid: 17408864
references.citation: Neurochem Int. 2012 Aug;61(3):415-22
references.pmid: 22584475
references.citation: Am J Physiol Renal Physiol. 2001 Sep;281(3):F454-68
references.pmid: 11502595
references.citation: J Neurochem. 2002 Jun;81(5):954-60
references.pmid: 12065607
references.citation: J Comp Neurol. 2009 Feb 1;512(4):529-55
references.pmid: 19025979
references.citation: Handb Exp Pharmacol. 2006;(175):151-80
references.pmid: 16722235
references.citation: J Neurosci. 2006 Aug 23;26(34):8758-66
references.pmid: 16928864
references.citation: J Neurosci. 2010 Nov 10;30(45):15185-95
references.pmid: 21068324
references.citation: J Biol Chem. 2004 Nov 26;279(48):50042-9
references.pmid: 15448143
references.citation: J Biol Chem. 2001 Nov 9;276(45):41611-9
references.pmid: 11553644
references.citation: J Neurosci. 1999 Sep 1;19(17):7356-66
references.pmid: 10460242
references.citation: Mol Pharmacol. 1993 Jul;44(1):129-41
references.pmid: 8393517
references.citation: Mol Pharmacol. 2005 Nov;68(5):1397-407
references.pmid: 16099839
references.citation: J Neurosci Res. 1998 Mar 1;51(5):551-8
references.pmid: 9511998
references.citation: PLoS One. 2012;7(3):e33719
references.pmid: 22442718
references.citation: Life Sci. 2000 Nov 24;68(1):81-90
references.pmid: 11132248
references.citation: Mol Pharmacol. 1999 Jul;56(1):1-10
references.pmid: 10385678
references.citation: J Neurochem. 2006 Apr;97(2):424-34
references.pmid: 16539668
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2002 Dec;366(6):620-3
references.pmid: 12444505
references.citation: Pharmacology. 2006;78(2):72-80
references.pmid: 16960463
references.citation: Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2542-6
references.pmid: 7681602
references.citation: J Pharmacol Exp Ther. 2010 Dec;335(3):743-53
references.pmid: 20858707
references.citation: Trends Pharmacol Sci. 2011 Apr;32(4):242-9
references.pmid: 21324537
references.citation: Glia. 1992;5(1):75-80
references.pmid: 1531812
references.citation: Inflamm Res. 2003 Apr;52 Suppl 1:S03-6
references.pmid: 12755385
references.citation: FEBS Lett. 1991 Dec 16;295(1-3):149-54
references.pmid: 1765147
references.citation: J Neurochem. 2002 Sep;82(5):1262-71
references.pmid: 12358773
references.citation: Proc Natl Acad Sci U S A. 1994 May 24;91(11):5158-62
references.pmid: 8197200
references.citation: Inflamm Res. 2009 Apr;58 Suppl 1:32-3
references.pmid: 19271125
references.citation: Neurosci Lett. 1987 Sep 11;80(1):106-10
references.pmid: 2889175
references.citation: Life Sci. 1984 Feb 13;34(7):691-9
references.pmid: 6700373
references.citation: Physiol Rev. 1991 Jan;71(1):1-51
references.pmid: 1846044
references.citation: Glia. 1990;3(3):159-68
references.pmid: 2141592
references.citation: Pharm Res. 2007 Jul;24(7):1227-51
references.pmid: 17473959
references.citation: J Neurosci Methods. 2011 Apr 15;197(1):118-27
references.pmid: 21345349
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18976-81
references.pmid: 19033200
references.citation: J Cereb Blood Flow Metab. 2012 Oct;32(10):1897-908
references.pmid: 22739622
references.citation: Nat Rev Neurosci. 2003 Feb;4(2):121-30
references.pmid: 12563283